3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
4
Sarcoma
2
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
CNS
1
Conditions
Gliosarcoma
7
Glioblastoma
6
Sarcoma
5
Brain Neoplasms
5
Astrocytoma
5
Oligodendroglioma
4
Neuroblastoma
3
Glioma
3
Wilms Tumor
2
Recurrence
2
Neoplasm Metastasis
2
Medulloblastoma
2
Lymphoma, Large B-Cell, Diffuse
2
Dendritic Cell Sarcoma, Interdigitating
2
Burkitt Lymphoma
2
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Optic Nerve Glioma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Meningioma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leiomyosarcoma
1
Hepatoblastoma
1
Familial ependymoma
1
Interventions
pembrolizumab
11
Gemcitabine
10
Doxorubicin
10
Cyclophosphamide
9
Specimen Handling
8
Nivolumab
8
Ibandronic Acid
8
pazopanib
7
Radiosurgery
6
Magnetic Resonance Spectroscopy
6
Imatinib Mesylate
6
Biopsy
6
Bevacizumab
6
Irinotecan
5
regorafenib
4
Zoledronic Acid
4
Ipilimumab
4
Ifosfamide
4
Fluorouracil
4
Docetaxel
4
Cetuximab
4
sargramostim
3
conatumumab
3
cemiplimab
3
Sunitinib
3
Radiation
3
Paclitaxel
3
Leucovorin
3
Cryosurgery
3
Cisplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Vorinostat
×
Sarcoma
×
Clear all
NCT01879085
2022-09-21
GemTax
University of Pittsburgh
Phase 1/2
Completed
37 enrolled
17 charts
NCT00918489
2018-10-17
SAHA-I
Heidelberg University
Phase 2
Completed
40 enrolled